Prebiotic/probiotic supplementation resulted in reduced visceral fat and mRNA expression associated with adipose tissue inflammation, systemic inflammation, and chronic disease risk

Table 1 Participant characteristics

Variable	Placebo (N = 7)	Supplement (N = 8)
Sex
(F)	5	3
(M)	2	5
Age
(Y)	21 ± 3	22 ± 7
Height (cm)	166 ± 6	169 ± 13
BMI (kg/m²)	27.6 ± 2.8	30.8 ± 3.5
Resting metabolic rate (kcal/day)	1603 ± 100	1871 ± 110

Probiotic Supplement (MegaDuo® Bacillus subtilis HU58 and Bacillus coagulans SC-208; 3 × 109 CFU/day; Microbiome Labs, LLC; Phoenix, AZ, USA). Values represent the mean ± standard error of the mean (SEM). Variable were compared between combined supplementation with prebiotic (PreticX® Xylooligosaccharide; 0.8 g/d; ADIP; City of Industry, CA) and probiotic (MegaDuo® Bacillus subtilis HU58 and Bacillus coagulans SC-208; 3 Billion CFU/d; NuScience Trading LLC; Phoenix, AZ) and Placebo (rice four) in free living overweight individuals over 90-d. No significant differences detected for participant characteristics between condition groups

ISSN: 1865-3499